This phase II trial is testing the drug cabozantinib in 50 patients with germ cell tumors that have not responded to standard chemotherapy. The goal is to see if the drug can stop or slow tumor growth. Patients take cabozantinib daily until the disease worsens or side effects bec…
Phase: PHASE2 • Sponsor: Jennifer King • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC